BBP

Featured

Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal

By Max ChenAugust 5, 2022

Featured

Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics

By Max ChenAugust 4, 2022

Featured

Biotech ETFs Are Making a Comeback

By Max ChenJuly 5, 2022

Innovative ETFs Channel

ACADIA Pharmaceuticals Help Lift Biotech ETFs

ACADIA Pharmaceuticals Help Lift Biotech ETFs

By Max ChenSeptember 9, 2019

Featured

Biotech Company Cara Therapeutics stock up 15% Up Big Amidst Sea Of Red Stocks

Biotech Company Cara Therapeutics (CARA) Up 15%

By Ian YoungMay 29, 2019

Featured

8 High Flying Biotech ETFs

8 High Flying Biotech ETFs for 2019

By Ian YoungMay 28, 2019

Equity ETFs

Sarepta Therapeutics Helps Biotech ETFs Buck Market Trend

Sarepta Therapeutics Helps Biotech ETFs Buck Market Trend

By Max ChenJune 19, 2018

Equity ETFs

Rising Rates May Hurt Small-Cap Biotech ETF Valuations

Rising Rates May Hurt Small-Cap Biotech ETF Valuations

By Max ChenDecember 23, 2016

Equity ETFs

Biotech ETFs Will Enjoy a More Favorable Environment

Biotech ETFs Will Enjoy a More Favorable Environment

By Max ChenNovember 29, 2016

Equity ETFs

etf-winners-losers-of-president-elect-trump

ETF Winners and Losers of President-Elect Trump

By Max ChenNovember 9, 2016

Featured

BBP: An Outperforming Biotechnology ETF

By Max ChenJuly 21, 2016

Equity ETFs

Biotech ETFs Rally as Earnings Boost Optimism

Biotech ETFs Rally as Earnings Boost Optimism

By Max ChenJuly 20, 2016

Equity ETFs

A Biotechnology ETF Proving Immune to Hawkish Fed Policy Changes

A Biotech ETF Proving Immune to Hawkish Fed Policy Changes

By Brenton GarenMay 4, 2016

Equity ETFs

Hit The Lab With These 17 Biotech ETFs

Hit The Lab With These 17 Biotech ETFs

By Tom LydonMay 2, 2016

Featured

Why This Biotech ETF Keeps Surging

By Tom LydonJuly 15, 2015

Featured

Investors Were Prepared for the Biotech Breakout

By Tom LydonJune 19, 2015

Featured

BioShares Biotech ETFs Boost Lineups, Increase Diversity

By Tom LydonJune 17, 2015

Featured

A New Biotech ETF Could Challenge Established Rivals

By Tom LydonJune 3, 2015

1 2 Next